Transitioning patients with severe haemophilia A from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: Real-world clinical experience

Robert Klamroth^{1

2

3}, Saskia Gottstein¹

Affiliations

¹ Vivantes Clinic in Friedrichshain, Internal Medicine, Vascular Medicine and Haemostaseology, Berlin, Germany.
² Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Medical Faculty, University of Bonn, Bonn, Germany.
³ Medical Faculty, University of Bonn, Bonn, Germany.

Robert Klamroth et al. Haemophilia. 2024 Sep.

. 2024 Sep;30(5):1247-1249.

doi: 10.1111/hae.15086. Epub 2024 Aug 13.

Robert Klamroth^{1

2

3}, Saskia Gottstein¹

¹ Vivantes Clinic in Friedrichshain, Internal Medicine, Vascular Medicine and Haemostaseology, Berlin, Germany.
² Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Medical Faculty, University of Bonn, Bonn, Germany.
³ Medical Faculty, University of Bonn, Bonn, Germany.

No abstract available

Publication types